SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-093514
Filing Date
2024-11-01
Accepted
2024-11-01 16:15:36
Documents
13
Period of Report
2024-10-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219197-8k_hoththera.htm   iXBRL 8-K 25309
  Complete submission text file 0001213900-24-093514.txt   200958

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hoth-20241030.xsd EX-101.SCH 3039
3 XBRL LABEL FILE hoth-20241030_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hoth-20241030_pre.xml EX-101.PRE 22375
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0219197-8k_hoththera_htm.xml XML 3787
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 241419281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)